United Kingdom · Question · Written question
UIN 3517
Bile Acid Malabsorption: Tirzepatide
Original
Introduced
20 May 2026
Last action
1 June 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
1 June 2026
Summary
To ask the Secretary of State for Health and Social Care, if he will request that NHS England and NICE evaluate the use of Tirzepatide, currently prescribed for weight loss on the NHS, as a potential treatment for Bile Acid Malabsorption.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
20 May 2026
Written question
To ask the Secretary of State for Health and Social Care, if he will request that NHS England and NICE evaluate the use of Tirzepatide, currently prescribed for weight loss on the NHS, as a potential treatment for Bile Acid Malabsorption.
Source: Commons
1 June 2026
Answer
In the United Kingdom, medicines need to have a licence before they can be marketed, and these are granted by the Medicines and Healthcare products Regulatory Agency. To get a licence, the manufacturer of the medicine must provide evidence which shows tha...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-05-20/3517
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1908074
- uk · wq-1908074 · source updated 1 June 2026